{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:15:32Z","timestamp":1763442932769,"version":"3.45.0"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012170","name":"Joseph and Silvana Melara Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Miliary brain metastasis (MM), consisting of innumerable miliary lesions in perivascular location, is a rare disease entity with an estimated incidence of 3.8% among patients with brain metastasis (BM). Similarly, with an approximated incidence of less than 2%, prostate cancer (PC)-related BM is also an infrequent presentation; however, it is more common in patients with neuroendocrine differentiation. To the best of our knowledge, only one other case of MM secondary to PC has been reported. This case report discusses two additional cases of PC-related MM, a condition otherwise predominantly observed secondary to pulmonary adenocarcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentations<\/jats:title>\n                    <jats:p>\n                      The first case describes a patient in his 60s known for metastatic PC with suspected neuroendocrine differentiation and presenting with musculoskeletal pain, lethargy, and status epilepticus. Contrast-enhanced computer tomography (CT) angiogram and magnetic resonance imaging (MRI) of the head and neck revealed diffuse and innumerable foci in the cerebral hemispheres, brainstem, and cerebellum. The second case discusses a similarly aged male patient with biopsy-proven\n                      <jats:italic>de novo<\/jats:italic>\n                      mixed adenocarcinoma\/small cell neuroendocrine PC and with symptoms consisting of significant weakness, aphasia, confusion, and decreased level of consciousness. Non-contrast-enhanced CT imaging of the brain did not reveal MM; however, a follow-up contrast-enhanced MRI detailed miliary lesions in the cortex, white matter, deep gray nuclei, brainstem, and cerebellum. Both patients expired within a couple of weeks from admission.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Given its rarity, notably in patients with PC, there are no specific and established diagnostic criteria for MM, a condition with ominous prognosis seemingly related to neuroendocrine differentiation in men with PC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1649587","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:13:19Z","timestamp":1763442799000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Rare meets rare\u2014miliary prostate cancer brain metastasis"],"prefix":"10.3389","volume":"15","author":[{"given":"Jaspreet K.","family":"Gill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Detsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyal","family":"Golan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Shiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urban","family":"Emmenegger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurpsyc.1951.02320020033003","article-title":"Encephalitic form of metastatic carcinoma","volume":"65","author":"Madow","year":"1951","journal-title":"AMA Arch NeurPsych"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10014-015-0235-3","article-title":"Brain metastasis: clinical characteristics, pathological findings and molecular subtyping for therapeutic implications","volume":"33","author":"Takei","year":"2016","journal-title":"Brain Tumor Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-006-0152-6","article-title":"Miliary brain metastases from adenocarcinoma of the lung: MR imaging findings with clinical and post-mortem histopathologic correlation","volume":"49","author":"Iguchi","year":"2007","journal-title":"Neuroradiology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-1008-2","article-title":"Central nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtype","volume":"123","author":"Bashour","year":"2020","journal-title":"Br J Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e9649","DOI":"10.7759\/cureus.9649","article-title":"Central nervous system miliary brain metastasis secondary to breast cancer: case report","volume":"12","author":"Santos V\u00e1zquez","year":"2020","journal-title":"Cureus"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2017.1328128","article-title":"Miliary metastases are associated with epidermal growth factor receptor mutations in non-small cell lung cancer: a population-based study","volume":"56","author":"Hsu","year":"2017","journal-title":"Acta Oncol (Madr)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-004-3346-y","article-title":"Miliary brain metastases from primary gastric small cell carcinoma: illustrating the seed and soil hypothesis","volume":"73","author":"Bugalho","year":"2005","journal-title":"J Neurooncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.3304","article-title":"Carcinomatosis encephalitis secondary to neuroendocrine transformation of prostate cancer","volume":"78","author":"Melendez-Zaidi","year":"2021","journal-title":"JAMA Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11144165","article-title":"Prostate cancer brain metastasis: review of a rare complication with limited treatment options and poor prognosis","volume":"11","author":"Rajeswaran","year":"2022","journal-title":"J Clin Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2020.02.152","article-title":"Prostate cancer brain metastases: A single-institution experience","volume":"138","author":"Bhambhvani","year":"2020","journal-title":"World Neurosurg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3791","article-title":"Platinum-based chemotherapy for variant castrate-resistant prostate cancer","volume":"19","author":"Aparicio","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02255-y","article-title":"Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation","volume":"41","author":"Merkens","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/19714009241240055","article-title":"The etiological spectrum of miliary brain lesions: A systematic review of published cases and case series","volume":"37","author":"Garg","year":"2024","journal-title":"Neuroradiol J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaa178","article-title":"Incidence and real-world burden of brain metastases from solid tumors and hematologic Malignancies in Ontario: a population-based study","volume":"3","author":"Habbous","year":"2020","journal-title":"Neurooncol Adv"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad344","article-title":"Large cell neuroendocrine prostate cancer: large is not small","volume":"29","author":"Serritella","year":"2024","journal-title":"Oncologist"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24664","article-title":"Diagnosis and management of neuroendocrine prostate cancer","volume":"84","author":"de Kouchkovsky","year":"2024","journal-title":"Prostate"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1649587\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:13:20Z","timestamp":1763442800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1649587\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":16,"alternative-id":["10.3389\/fonc.2025.1649587"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1649587","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"article-number":"1649587"}}